Opportunity Information: Apply for PAR 14 267
Apply for PAR 14 267
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Outstanding Investigator Award (R35)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control.
- This funding opportunity was created on Jun 27, 2014 and posted on Jun 27, 2014.
- Applicants must submit their applications by Jan 7, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $600,000.00 in funding.
- Eligible applicants include: Special district governments Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts City or township governments Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Private institutions of higher education Public housing authorities/Indian housing authorities Small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Foreign Institutions Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Outstanding Investigator Award (R35), listed as PAR-14-267, is a National Cancer Institute (NCI) funding opportunity under the National Institutes of Health (NIH) designed to support experienced cancer researchers with strong, proven records of productivity and impact. The central idea is to provide long-term, stable funding so established investigators can pursue ambitious and potentially high-reward directions in cancer research without being constrained by short grant cycles or overly narrow project scopes. By giving investigators room to explore, the program is meant to encourage bolder scientific choices, including pursuing unconventional hypotheses, shifting into new research directions, or investing time in developing new methods or technologies that could unlock future breakthroughs.
This award is open to applications in essentially any area of cancer research, spanning biomedical, behavioral, and clinical domains. The work proposed is expected to be exceptional and to either break new ground or push prior discoveries into novel directions or applications. In practical terms, NCI is looking for research programs that are not just incremental extensions of existing work, but efforts with unusual potential to produce major advances in understanding, preventing, detecting, diagnosing, treating, or controlling cancer. The FOA explicitly frames the R35 as a mechanism to let investigators take greater scientific risks and be more adventurous, which is often difficult under traditional, shorter-term grant structures.
A defining feature of this opportunity is that the application is submitted by an institution nominating an established Program Director/Principal Investigator (PD/PI) for a single, extended award period of seven years. That structure is intended to strengthen continuity and reduce the administrative and strategic disruption that can come with frequent renewals or constant re-competition for funding. The expectation is that this longer runway will help investigators plan and execute complex research agendas, pivot when results point in unexpected directions, and sustain momentum on challenging problems that may take years to mature into transformative outcomes.
From an administrative standpoint, this is a discretionary grant mechanism with an award ceiling listed at $600,000 (as provided in the source data). There is no cost-sharing or matching requirement stated for this opportunity. The program aligns with multiple cancer-related CFDA numbers, including cancer cause and prevention, detection and diagnosis, treatment, biology, and control, reflecting how broadly it is meant to apply across NCI’s scientific mission areas.
Eligibility is broad across U.S.-based organizations and governmental entities. Eligible applicants include public and private institutions of higher education, nonprofits (including both 501(c)(3) and certain non-501(c)(3) organizations), for-profit organizations other than small businesses, small businesses, and a wide range of government entities such as state, county, city/township, special district governments, and certain public housing authorities/Indian housing authorities. The opportunity also highlights eligibility for a number of institution types and community-serving organizations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations and eligible federal agencies. At the same time, foreign institutions and non-U.S. entities are not eligible to apply, and foreign components are not allowed under NIH policy as referenced in the announcement.
Key dates in the source listing show the opportunity was posted on June 27, 2014, with an original and current closing date of January 7, 2015, and an archive date of February 7, 2015. The full announcement was made available through the NIH Grants Guide at the link provided in the source data. For technical access or linking issues, the contact point listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Overall, this FOA is aimed at backing top-tier, established cancer investigators with a long, stable funding horizon so they can pursue research with the kind of scale, uncertainty, and creativity that can lead to major advances, rather than being limited to safer, shorter-term aims.
Outstanding Investigator Award (R35) (PAR-14-267) - FAQs
What is the Outstanding Investigator Award (R35) (PAR-14-267)?
The Outstanding Investigator Award (R35), PAR-14-267, is a National Cancer Institute (NCI) funding opportunity under the National Institutes of Health (NIH) intended to support experienced, highly productive cancer researchers. Its purpose is to provide long-term, stable support so established investigators can pursue ambitious, potentially high-reward cancer research directions without being constrained by short grant cycles or overly narrow project scopes.
What is the main goal of this funding opportunity?
The central goal is to enable exceptional investigators to take greater scientific risks and pursue bolder research programs. The award is structured to encourage unconventional hypotheses, shifts into new research directions, and development of new methods or technologies that could lead to future breakthroughs in cancer research.
Who is this award designed to support?
This award is designed for experienced cancer researchers with strong, proven records of productivity and impact. The opportunity is aimed at established investigators whose work is expected to be exceptional and positioned to produce major advances rather than incremental progress.
What kinds of cancer research areas are eligible under this FOA?
Applications are accepted in essentially any area of cancer research, including biomedical, behavioral, and clinical domains. The program is broadly aligned with NCI mission areas such as understanding, preventing, detecting, diagnosing, treating, and controlling cancer.
What level or type of research is NCI looking for?
NCI is looking for research programs with unusual potential to produce major advances. The FOA emphasizes that proposed work should break new ground or push prior discoveries into novel directions or applications, rather than serving as an incremental extension of existing work.
How does this award differ from more traditional grant structures?
A defining feature is the long, stable funding horizon intended to reduce disruption from frequent renewals and re-competition. The FOA frames the R35 mechanism as a way to give investigators room to explore, pivot when results point in unexpected directions, and invest in approaches that may take years to mature.
How long is the award period?
The nomination and application are for a single, extended award period of seven years.
Who submits the application?
The application is submitted by an institution nominating an established Program Director/Principal Investigator (PD/PI).
What is the maximum award amount listed for this opportunity?
The source listing indicates an award ceiling of $600,000.
Is cost sharing or matching required?
No cost-sharing or matching requirement is stated for this opportunity.
What type of funding mechanism is this?
This opportunity is described as a discretionary grant mechanism.
What organizations are eligible to apply?
Eligibility is broad across U.S.-based organizations and governmental entities. Eligible applicants include public and private institutions of higher education; nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) organizations); for-profit organizations other than small businesses; small businesses; and multiple types of government entities such as state, county, city/township, and special district governments, as well as certain public housing authorities/Indian housing authorities.
Are minority-serving institutions included as eligible applicants?
Yes. The opportunity highlights eligibility for institution types and community-serving organizations including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs).
Are faith-based or community-based organizations eligible?
Yes. The opportunity notes eligibility for faith-based or community-based organizations (among other eligible applicant types).
Are federal agencies eligible to apply?
The opportunity indicates that eligible federal agencies may apply.
Are foreign institutions or non-U.S. entities eligible to apply?
No. Foreign institutions and non-U.S. entities are not eligible to apply.
Are foreign components allowed?
No. Foreign components are not allowed under NIH policy as referenced in the announcement.
When was this opportunity posted?
The source listing shows the opportunity was posted on June 27, 2014.
What was the closing date for applications?
The source listing shows an original and current closing date of January 7, 2015.
Is this funding opportunity archived?
Yes. The source listing shows an archive date of February 7, 2015.
Where was the full announcement published?
The full announcement was made available through the NIH Grants Guide (as referenced in the source data).
Who should be contacted for technical access or linking issues?
For technical access or linking issues, the listed contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: FA BLM AZ Environmental Quality Website Enhancements and Modification
Previous opportunity: POTENTIAL
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 14 267
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 14 267) also looked into and applied for these:
| Funding Opportunity |
|---|
| The National Drug Abuse Treatment Clinical Trials Network (UG1) Apply for RFA DA 15 008 Funding Number: RFA DA 15 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Connectomes Related to Human Disease (U01) Apply for PAR 14 281 Funding Number: PAR 14 281 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Extracellular Vesicles in HIV/AIDS and Substance Abuse (R01) Apply for RFA DA 15 011 Funding Number: RFA DA 15 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Extracellular Vesicles in HIV/AIDS and Substance Abuse (R21) Apply for RFA DA 15 012 Funding Number: RFA DA 15 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Innovative Research in Cancer Nanotechnology (IRCN) (U01) Apply for PAR 14 285 Funding Number: PAR 14 285 Agency: National Institutes of Health Category: Education Health Funding Amount: $450,000 |
| Centers of Cancer Nanotechnology Excellence (CCNEs) (U54) Apply for RFA CA 14 013 Funding Number: RFA CA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Interventions for Youth who Misuse/Abuse Prescription Stimulant Medications in High School and/or College Attending Youth (U01) Apply for RFA DA 15 010 Funding Number: RFA DA 15 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Arts Based Approaches in Palliative Care for Symptom Management (R01) Apply for PAR 14 294 Funding Number: PAR 14 294 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Cancer Intervention and Surveillance Modeling Network (CISNET) (U01) Apply for RFA CA 14 012 Funding Number: RFA CA 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| New Approaches to Synthetic Lethality for Mutant KRas Dependent Cancers (U01) Apply for PAR 14 314 Funding Number: PAR 14 314 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Obesity and Asthma Awareness and Self Management (R01) Apply for PA 14 316 Funding Number: PA 14 316 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition AIDS Malignancy Clinical Trials Consortium (UM1) Apply for RFA CA 14 502 Funding Number: RFA CA 14 502 Agency: National Institutes of Health Category: Education Health Funding Amount: $21,400,000 |
| Developing Interventions for Health Enhancing Physical Activity (R21/R33) Apply for PAR 14 321 Funding Number: PAR 14 321 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Training Modules to Enhance Data Reproducibility (R25) Apply for RFA GM 15 006 Funding Number: RFA GM 15 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Limited Competition International Agency for Research on Cancer (IARC) Monographs Program (U01) Apply for RFA CA 14 503 Funding Number: RFA CA 14 503 Agency: National Institutes of Health Category: Education Health Funding Amount: $859,000 |
| Advancing Interventions to Improve Medication Adherence (R21) Apply for PA 14 335 Funding Number: PA 14 335 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13) Apply for PAR 14 339 Funding Number: PAR 14 339 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Self Management for Health in Chronic Conditions (R01) Apply for PA 14 344 Funding Number: PA 14 344 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Self Management for Health in Chronic Conditions (R21) Apply for PA 14 343 Funding Number: PA 14 343 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Self Management for Health in Chronic Conditions (R15) Apply for PA 14 345 Funding Number: PA 14 345 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 14 267", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.